MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
2.61 M |
Market Cap[1] |
$ 313 K |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
RadNet
RDNT
|
$ 78.05 | -2.75 % | $ 5.87 B | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Sotera Health Company
SHC
|
$ 15.87 | -3.2 % | $ 4.51 B | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 10.6 | -5.44 % | $ 360 M | Nasdaq Global Select Market |  Israel |
 |
Neuronetics
STIM
|
$ 2.43 | -10.17 % | $ 160 M | Nasdaq Global Select Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 676.84 | -4.18 % | $ 255 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 5.9 | -8.28 % | $ 2.12 B | Nasdaq Global Select Market |  Irlanda |
 |
VolitionRx Limited
VNRX
|
$ 0.2 | -3.92 % | $ 25.2 M | NYSE American |  Singapore |
 |
Waters Corporation
WAT
|
$ 453.45 | -2.87 % | $ 27 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 7.6 | -10.69 % | $ 164 M | Nasdaq Global Market | USA |
 |
Illumina
ILMN
|
$ 207.8 | -8.27 % | $ 32.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 634.61 | -3.37 % | $ 18.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market |  Schweiz |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market |  Britain |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Celcuity
CELC
|
$ 63.94 | -7.35 % | $ 2.99 B | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 7.98 | -11.53 % | $ 333 M | NYSE American | USA |
 |
IQVIA Holdings
IQV
|
$ 265.11 | 0.5 % | $ 45.6 B | NYSE,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.01 | -8.23 % | $ 97.7 K | Nasdaq Capital Market | USA |
|
Biodesix
BDSX
|
$ 19.8 | -7.86 % | $ 150 M | Nasdaq Global Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.12 | -6.3 % | $ 6.1 M | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 10.65 | -6.74 % | $ 710 M | Nasdaq Global Select Market | USA |
 |
IDEXX Laboratories
IDXX
|
$ 670.93 | -3.95 % | $ 54 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.63 | -5.34 % | $ 573 M | Nasdaq Global Market | USA |
 |
CareDx, Inc
CDNA
|
$ 76.31 | -11.13 % | $ 4.07 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | Britain |
 |
Biomerica
BMRA
|
$ 1.61 | -7.2 % | $ 4.69 M | Nasdaq Capital Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 7.0 | 22.38 % | $ 31 M | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 201.41 | -0.84 % | $ 15.8 B | Nasdaq Global Select Market,SPB | Irlanda |
 |
Co-Diagnostics
CODX
|
$ 0.27 | -24.13 % | $ 359 K | Nasdaq Capital Market | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 13.26 | 3.35 % | $ 139 M | Nasdaq Global Market |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 2.74 | -7.74 % | $ 10.9 M | Nasdaq Capital Market | Israel |
 |
QIAGEN N.V.
QGEN
|
$ 50.87 | 0.11 % | $ 11 B | NYSE |  Niderland |
 |
Myriad Genetics
MYGN
|
$ 6.29 | 4.49 % | $ 582 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.01 | 1.32 % | $ 3.94 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 16.48 | -3.91 % | $ 2.11 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.75 | -1.41 % | $ 1.31 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.